Soo-Jin Kim
Chief Tech/Sci/R&D Officer en INOZYME PHARMA, INC. .
Fortuna: 2 M $ al 31/03/2024
Perfil
Soo-Jin Kim is currently the Chief Technical Operations Officer & Senior VP at Inozyme Pharma, Inc. Prior to this, he worked as a Principal Scientist at Bristol Myers Squibb Co., Senior Research & Head-API Development Group at Boehringer Ingelheim Pharmaceuticals, Inc., and Senior Vice President & Head-Bio Plant at Hanmi Pharmaceutical Co., Ltd.
Kim received his undergraduate degree from Cornell University and his graduate and doctorate degrees from the California Institute of Technology.
Participaciones conocidas en empresas públicas
| Empresa | Fecha | Número de acciones | Valoración | Fecha de valoración |
|---|---|---|---|---|
ILSHIN SPINNING CO., LTD
1.31% | 26/04/2023 | 305 460 ( 1.31% ) | 2 M $ | 31/03/2024 |
Cargos activos de Soo-Jin Kim
| Empresas | Cargo | Inicio |
|---|---|---|
| INOZYME PHARMA, INC. | Chief Tech/Sci/R&D Officer | 08/03/2022 |
Antiguos cargos conocidos de Soo-Jin Kim.
| Empresas | Cargo | Fin |
|---|---|---|
Boehringer Ingelheim Pharmaceuticals, Inc.
 Boehringer Ingelheim Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Boehringer Ingelheim Pharmaceuticals, Inc. manufactures pharmaceuticals products. It develops and markets drugs for the treatment of respiratory, cancer, cardiovascular, immunological and central nervous system diseases. The company was founded in 1971 and is headquartered in Ridgefield, CT. | Corporate Officer/Principal | - |
| HANMI PHARM. CO., LTD. | Corporate Officer/Principal | - |
| BRISTOL-MYERS SQUIBB COMPANY | Corporate Officer/Principal | - |
Formación de Soo-Jin Kim.
| Cornell University | Undergraduate Degree |
| California Institute of Technology | Doctorate Degree |
Experiencias
Funciones ocupadas
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Relaciones
Relaciones de 1er grado
Empresas vinculadas al 1er grado
Hombre
Mujer
Administradores
Ejecutivos
Empresas relacionadas
| Empresas cotizadas | 3 |
|---|---|
| BRISTOL-MYERS SQUIBB COMPANY | Health Technology |
| HANMI PHARM. CO., LTD. | Health Technology |
| INOZYME PHARMA, INC. | Health Technology |
| Empresas privadas | 1 |
|---|---|
Boehringer Ingelheim Pharmaceuticals, Inc.
Boehringer Ingelheim Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Boehringer Ingelheim Pharmaceuticals, Inc. manufactures pharmaceuticals products. It develops and markets drugs for the treatment of respiratory, cancer, cardiovascular, immunological and central nervous system diseases. The company was founded in 1971 and is headquartered in Ridgefield, CT. | Health Technology |
- Bolsa de valores
- Insiders
- Soo-Jin Kim
